ArticleHuman gene therapy2014

A human ErbB2-specific T-cell receptor confers potent antitumor effector functions in genetically engineered primary cytotoxic lymphocytes.

Evripidis Lanitis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.